• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体药物偶联物的分析和生物分析技术。

Analytical and bioanalytical technologies for characterizing antibody-drug conjugates.

机构信息

Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, WA 98021, United States.

出版信息

Curr Opin Chem Biol. 2013 Jun;17(3):406-11. doi: 10.1016/j.cbpa.2013.03.022. Epub 2013 Apr 6.

DOI:10.1016/j.cbpa.2013.03.022
PMID:23570980
Abstract

Antibody-drug conjugates (ADCs) require multiple assays for analytical and bioanalytical characterization due to their heterogeneous and dynamic nature. These assays can help address questions from the drug-loading distribution following conjugation to exposure-response relationships after dosing in vivo. This review describes new assay technologies that have been developed for physiochemical characterization and determination of pharmacokinetic parameters of ADCs.

摘要

抗体偶联药物(ADCs)由于其异质性和动态特性,需要进行多种分析和生物分析特性鉴定检测。这些检测有助于解决从偶联后药物载量分布到体内给药后暴露-反应关系等问题。本文综述了新的检测技术,这些技术已经被开发出来用于 ADC 的物理化学特性分析和药代动力学参数的测定。

相似文献

1
Analytical and bioanalytical technologies for characterizing antibody-drug conjugates.抗体药物偶联物的分析和生物分析技术。
Curr Opin Chem Biol. 2013 Jun;17(3):406-11. doi: 10.1016/j.cbpa.2013.03.022. Epub 2013 Apr 6.
2
Challenges in developing bioanalytical assays for characterization of antibody-drug conjugates.开发用于表征抗体-药物偶联物的生物分析方法所面临的挑战。
Bioanalysis. 2011 Mar;3(6):677-700. doi: 10.4155/bio.11.30.
3
Biotransformation and stability of antibody-drug conjugates: payload metabolism and linker cleavage delineation.
Bioanalysis. 2015;7(11):1319-23. doi: 10.4155/bio.15.50.
4
Analytical methods for physicochemical characterization of antibody drug conjugates.抗体药物偶联物理化特性分析方法。
MAbs. 2011 Mar-Apr;3(2):161-72. doi: 10.4161/mabs.3.2.14960. Epub 2011 Mar 1.
5
Linker technologies for antibody-drug conjugates.抗体药物偶联物的连接子技术
Methods Mol Biol. 2013;1045:71-100. doi: 10.1007/978-1-62703-541-5_5.
6
Formulation development of antibody-drug conjugates.
Methods Mol Biol. 2013;1045:217-33. doi: 10.1007/978-1-62703-541-5_13.
7
Recent advances in the construction of antibody-drug conjugates.抗体偶联药物构建的最新进展。
Nat Chem. 2016 Feb;8(2):114-9. doi: 10.1038/nchem.2415. Epub 2016 Jan 4.
8
Risk-based scientific approach for determination of extractables/leachables from biomanufacturing of antibody-drug conjugates (ADCs).
Methods Mol Biol. 2013;1045:303-11. doi: 10.1007/978-1-62703-541-5_20.
9
Immunogenicity testing strategy and bioanalytical assays for antibody-drug conjugates.抗体药物偶联物的免疫原性检测策略及生物分析方法
Bioanalysis. 2013 May;5(9):1041-55. doi: 10.4155/bio.13.10.
10
Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paper.抗体药物偶联物的生物分析:美国药学科学家协会抗体药物偶联物工作组立场文件。
Bioanalysis. 2013 May;5(9):997-1006. doi: 10.4155/bio.13.38.

引用本文的文献

1
Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities.抗体药物偶联物作为靶向癌症治疗的方法:过去的发展、当前的挑战和未来的机遇。
Arch Pharm Res. 2023 May;46(5):361-388. doi: 10.1007/s12272-023-01447-0. Epub 2023 Apr 18.
2
Current LC-MS-based strategies for characterization and quantification of antibody-drug conjugates.当前基于液相色谱-质谱联用技术的抗体药物偶联物表征与定量策略。
J Pharm Anal. 2020 Jun;10(3):209-220. doi: 10.1016/j.jpha.2020.05.008. Epub 2020 May 23.
3
Application of triple quadrupole mass spectrometry for the characterization of antibody-drug conjugates.
三重四极杆质谱法在抗体药物偶联物表征中的应用。
Anal Bioanal Chem. 2019 May;411(12):2569-2576. doi: 10.1007/s00216-019-01699-0. Epub 2019 Mar 8.
4
Chemical Structure and Concentration of Intratumor Catabolites Determine Efficacy of Antibody Drug Conjugates.肿瘤内分解代谢物的化学结构和浓度决定抗体药物偶联物的疗效。
Drug Metab Dispos. 2016 Sep;44(9):1517-23. doi: 10.1124/dmd.116.070631. Epub 2016 Jul 14.
5
An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugates.一种用于分析抗体药物偶联物上小分子活性药物的酶促去共轭方法。
MAbs. 2016 May-Jun;8(4):698-705. doi: 10.1080/19420862.2016.1151590. Epub 2016 Feb 18.
6
Computational Construction of Antibody-Drug Conjugates Using Surface Lysines as the Antibody Conjugation Site and a Non-cleavable Linker.使用表面赖氨酸作为抗体偶联位点和不可裂解连接子的抗体-药物偶联物的计算构建
Cancer Inform. 2014 Dec 8;13:179-86. doi: 10.4137/CIN.S19222. eCollection 2014.
7
Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates.抗体药物偶联物研发的临床前药代动力学考量
Pharm Res. 2015 Nov;32(11):3470-9. doi: 10.1007/s11095-014-1584-z. Epub 2014 Dec 2.
8
Antibody therapy for pediatric leukemia.儿童白血病的抗体疗法。
Front Oncol. 2014 Apr 21;4:82. doi: 10.3389/fonc.2014.00082. eCollection 2014.
9
Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion.LC-MS 法结合 IdeS 酶切快速鉴定抗体偶联药物。
MAbs. 2014 Jan-Feb;6(1):273-85. doi: 10.4161/mabs.26773.